Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Thursday, July 17, 2014 10:51:52 AM
bullish 50-75% in a week on margin or more longer term
wake up neo...
## source: finance.yahoo.com
Thu, 17 Jul 2014 12:50:30 GMT ~ NEOGENOMICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/140717/neo8-k.html
*********************************************************
Thu, 17 Jul 2014 11:32:45 GMT ~ NeoGenomics Reports Record Revenues of $20.7 Million on 40% Test Volume Growth and Expanding Gross Margins for the Second Quarter 2014
[at noodls] - Company Raises Full-Year Revenue Guidance to $83 - $86 Million FT. MYERS, Fla., July 17, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services ...
read full: http://www.noodls.com/view/44ADEBA849BE16FD5787FC43B3CB9AE4DC4803E3
*********************************************************
Thu, 17 Jul 2014 11:07:02 GMT ~ Q2 2014 Neogenomics Inc Earnings Release - Before Market Open
read full: http://biz.yahoo.com/research/earncal/20140717.html?t=neo
*********************************************************
Thu, 17 Jul 2014 11:07:00 GMT ~ 7:07 am NeoGenomics reports EPS in-line with recent guidance and consensus, beats on revs/guidance; guides Q3/FY14 EPS in-line, revs above consensus
read full: http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#neo
*********************************************************
Thu, 17 Jul 2014 11:00:00 GMT ~ NeoGenomics Reports Record Revenues of $20.7 Million on 40% Test Volume Growth and Expanding Gross Margins for the Second Quarter 2014
[PR Newswire] - FT. MYERS, Fla., July 17, 2014 /PRNewswire/ -- NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services today reported its results for the second quarter of 2014. ...
read full: http://finance.yahoo.com/news/neogenomics-reports-record-revenues-20-110000646.html
*********************************************************
$NEO charts
basic chart ## source: stockcharts.com
basic chart ## source: eoddata.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$NEO company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/NEO/company-info
Ticker: $NEO
OTC Market Place: Not Available
CIK code: 0001077183
Company name: NeoGenomics, Inc.
Company website: http://www.neogenomics.org
Incorporated In: NV, USA
Business Description: NeoGenomics Laboratories is a specialized genetics laboratory providing the latest diagnostic testing technologies to the pathology and oncology Communities. Staffed with specially trained hematopathologists and cytogenetic professionals, NeoGenomics Laboratories offers testing in cancer genetics, flow cytometry, immunohistochemistry and molecular diagnostics through its network of regional laboratories.
$NEO share structure
## source: otcmarkets.com
Market Value: $217,613,853 a/o Jul 16, 2014
Shares Outstanding: 49,683,528 a/o May 02, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$NEO extra dd links
Company name: NeoGenomics, Inc.
Company website: http://www.neogenomics.org
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/NEO/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/NEO/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=NEO+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=NEO+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=NEO+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/NEO/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/NEO/news - http://finance.yahoo.com/q/h?s=NEO+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/NEO/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/NEO/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/NEO/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/NEO/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/NEO/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/NEO/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/NEO/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/NEO/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=NEO+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/NEO
DTCC (dtcc.com): http://search2.dtcc.com/?q=NeoGenomics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=NeoGenomics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=NeoGenomics%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.neogenomics.org
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.neogenomics.org#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.neogenomics.org
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/NEO/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/NEO
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/NEO/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/NEO/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/NEO/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001077183&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/NEO/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/NEO/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/NEO/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/NEO/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=NEO&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=NEO
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/NEO/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=NEO+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=NEO+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=NEO
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=NEO
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=NEO+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/NEO/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=NEO+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/NEO.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=NEO
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/NEO/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/NEO/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/NEO/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/NEO/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/NEO
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/NEO
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/NEO:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=NEO
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=NEO
$NEO DD Notes ~ http://www.ddnotesmaker.com/NEO
a11k
Recent NEO News
- NeoGenomics Reports First Quarter 2024 Results • Business Wire • 04/30/2024 11:30:00 AM
- NeoGenomics Announces Senior Leadership Promotions • Business Wire • 04/18/2024 11:05:00 AM
- NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024 • Business Wire • 04/09/2024 11:00:00 AM
- NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting • Business Wire • 03/27/2024 12:30:00 PM
- NeoGenomics Releases Inaugural Environmental, Social, and Governance (ESG) Report • Business Wire • 03/20/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:26:13 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:33:35 PM
- NeoGenomics to Participate in the TD Cowen 44th Annual Health Care Conference • Business Wire • 03/01/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:29:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:28:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:28:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:27:59 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 02/26/2024 09:15:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/20/2024 09:32:59 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/20/2024 09:23:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:06:34 PM
- NeoGenomics Reports Fourth Quarter and Full Year 2023 Results • Business Wire • 02/20/2024 09:05:00 PM
- Market Cautiousness Ahead of Retail Giants’ Earnings; Oil Prices Dip • IH Market News • 02/20/2024 10:37:35 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/15/2024 09:26:23 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 03:04:34 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 08:17:09 PM
- NeoGenomics Signs Working with Cancer Pledge in Support of Employees • Business Wire • 02/01/2024 12:05:00 PM
- NeoGenomics to Report Fourth Quarter and Full Year 2023 Financial Results on February 20, 2024 • Business Wire • 01/30/2024 12:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2024 10:28:20 PM
- NeoGenomics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference • Business Wire • 01/02/2024 12:05:00 PM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM